Growth Metrics

Sarepta Therapeutics (SRPT) Total Debt Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 6.94%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 50.25%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.07%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn -12.10%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -12.10%
Dec 31, 2025 -18.73%
Sep 30, 2025 -11.45%
Jun 30, 2025 1.15%
Mar 31, 2025 1.18%
Dec 31, 2024 1.21%
Sep 30, 2024 3.89%
Jun 30, 2024 3.91%
Mar 31, 2024 4.33%
Dec 31, 2023 7.65%
Sep 30, 2023 20.86%
Jun 30, 2023 21.19%
Mar 31, 2023 21.51%
Dec 31, 2022 31.32%
Sep 30, 2022 52.33%
Jun 30, 2022 36.69%
Mar 31, 2022 37.17%
Dec 31, 2021 37.65%
Sep 30, 2021 38.13%
Jun 30, 2021 35.49%
Mar 31, 2021 36.31%
Dec 31, 2020 32.05%
Sep 30, 2020 181.86%
Jun 30, 2020 295.54%
Mar 31, 2020 269.03%
Dec 31, 2019 248.22%
Sep 30, 2019 186.29%
Jun 30, 2019 177.29%
Mar 31, 2019 172.77%
Dec 31, 2018 171.97%
Sep 30, 2018 171.18%
Jun 30, 2018 176.66%
Mar 31, 2018 552.75%
Dec 31, 2017 549.39%
Sep 30, 2017 136.69%
Jun 30, 2017 90.56%
Mar 31, 2017 102.64%
Dec 31, 2016 15.13%
Sep 30, 2016 -20.91%
Jun 30, 2016 127.72%
Mar 31, 2016 129.52%
Dec 31, 2015 128.29%
Mar 31, 2015 -5.25%
Dec 31, 2014 -5.11%
Sep 30, 2014 8.21%
Jun 30, 2014 -4.87%
Dec 31, 2013 76.55%